Histamine H3 Receptor Antagonist Enhances Neurogenesis and Improves Chronic Cerebral Hypoperfusion-Induced Cognitive Impairments
Chronic cerebral hypoperfusion (CCH) is a neurodegenerative disease, which induces cognitive impairments in the central nervous system (CNS). Histamine H3 receptor (H3R) is an autoreceptor involved in the modulation of neurogenesis and synaptic plasticity in the CNS. However, the role of H3R in CCH-...
主要な著者: | Na Wang, Jing Ma, Jing Liu, Jiangong Wang, Cuilan Liu, Hua Wang, Yong Liu, Haijing Yan, Shujun Jiang |
---|---|
フォーマット: | 論文 |
言語: | English |
出版事項: |
Frontiers Media S.A.
2020-01-01
|
シリーズ: | Frontiers in Pharmacology |
主題: | |
オンライン・アクセス: | https://www.frontiersin.org/article/10.3389/fphar.2019.01583/full |
類似資料
-
FTY720 Prevents Spatial Memory Impairment in a Rat Model of Chronic Cerebral Hypoperfusion via a SIRT3-Independent Pathway
著者:: Miao Zhang, 等
出版事項: (2021-01-01) -
Enhancement of the anticonvulsant effect of the h3 histamine receptor blocker thioperamid against the use of pioglitazone
著者:: O. Yehorenko, 等
出版事項: (2022-04-01) -
Cortex-specific transcriptome profiling reveals upregulation of interferon-regulated genes after deeper cerebral hypoperfusion in mice
著者:: Zengyu Zhang, 等
出版事項: (2023-03-01) -
The involvement of central nervous system histamine receptors in psychological stress-induced exacerbation of allergic airway inflammation in mice
著者:: Tomomitsu Miyasaka, 等
出版事項: (2016-09-01) -
Baseline Characteristics Associated with Good Collateral Status Using Hypoperfusion Index as an Outcome
著者:: Omar Hamam, 等
出版事項: (2022-07-01)